Czechia vs Lithuania: Share of e coli bloodstream infections due to antimicrobial resistant
Czechia
14.45
in 2022
Lithuania
17.03
in 2022
Czechia rank
35th
Lithuania rank
32nd
Share of e coli bloodstream infections due to antimicrobial resistant over time
- Czechia
- Lithuania
How they compare
Lithuania currently reports 17.03 against 14.45 in Czechia, a difference of 2.58.
That makes Lithuania's figure about 1.2 times Czechia's.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was Czechia ahead.
Czechia ranks 35th and Lithuania ranks 32nd of 46 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14.92 | 15.12 | 0.2 | Lithuania |
| 2020s | 13.95 | 15.56 | 1.61 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e coli bloodstream infections due to antimicrobial resistant, Czechia or Lithuania?
- Lithuania, at 17.03 against 14.45 in Czechia as of 2022.
- What is the difference in share of e coli bloodstream infections due to antimicrobial resistant between Czechia and Lithuania?
- 2.58, with Lithuania ahead.
- How many years of comparable data are there for Czechia and Lithuania?
- 6 years are reported by both, from 2017 to 2022.
- How do Czechia and Lithuania rank globally for share of e coli bloodstream infections due to antimicrobial resistant?
- Czechia ranks 35th and Lithuania ranks 32nd of 46 countries.
- Where does this data come from?
- Our World in Data, published as Share of e coli bloodstream infections due to antimicrobial resistant bacteria. Statizoid refreshes it automatically from the source and publishes the full history for both places.